Why did Quaker Houghton announce a new $250M repurchase program?

The company announced the program in conjunction with strong operational results—Q2'26 adjusted EBITDA was up 13% year-over-year and the company reported consecutive quarters of profitability growth. The new program replaces the prior 2024 Share Repurchase Plan and provides management with discretionary capital-return flexibility alongside the company's dividend increase.

What was the average price Quaker Houghton paid for shares in Q2'26?

The filing does not disclose the average price per share. It states only that 170,568 shares were repurchased for approximately $24.2 million in Q2'26. Investors can calculate the implied average price (~$142 per share) but the filing does not explicitly state this figure.

How long is the authorization valid?

The new program has no expiration date, unlike time-limited programs common in some companies. This gives management ongoing discretion to repurchase shares as market conditions and cash flow permit, without needing to renew authorization by a specific deadline.

How does the buyback fit with Quaker Houghton's debt levels?

The company's net debt stood at approximately $721 million at June 30, 2026, representing 2.3x trailing twelve-month adjusted EBITDA. At that leverage ratio, the company maintains financial flexibility to execute the buyback while servicing debt and funding operations, though debt reduction remains a priority given historical leverage targets in the 2.0x–2.5x range.

Does the filing specify how Quaker will execute the buyback?

No. The filing does not disclose whether repurchases will occur under Rule 10b-18 open-market purchases, a 10b5-1 trading plan, accelerated share repurchase agreements, or another mechanism. Additional details on execution strategy typically appear in separate Form 8-K or in the company's investor relations disclosures.

How much of the $250M authorization remains available?

The filing does not provide the dollar amount remaining under the authorization. With $24.2 million deployed in Q2'26, approximately $225.8 million would remain available as of the earnings release date (July 30, 2026), but formal disclosure of cumulative repurchases under the new plan may be found in subsequent quarterly SEC filings.

KWR 8-K Filed 2026-07-30 New authorization

Quaker Houghton authorizes new $250M share repurchase program

Replaces 2024 plan; company repurchased $24.2M in Q2'26 at undisclosed average price

Authorization$250M

MechanismNot specified

What the filing says

Quaker Houghton announced a new $250 million share repurchase program in Q2 2026, replacing the 2024 Share Repurchase Plan and carrying no expiration date. The newly authorized program provides the company with continued flexibility to return capital to shareholders as it demonstrates improving profitability and cash generation.

During the second quarter of 2026, the company executed repurchases of 170,568 shares for approximately $24.2 million. The filing does not specify the execution mechanism (e.g., open-market purchases under Rule 10b-18 or otherwise) or the average price paid per share during the period.

The buyback announcement was made alongside strong operational results: Q2'26 net sales of $532.6 million (up 10% year-over-year), net income of $26.8 million, and adjusted EBITDA of $85.2 million (up 13% year-over-year). The company also increased its quarterly dividend by approximately 4.3% in the same period, signaling confidence in cash flow generation and shareholder returns.

In the second quarter of 2026, the Company announced a new share repurchase program authorizing the Company to repurchase up to an aggregate of $250 million of Quaker Chemical Corporation common stock, which replaced the 2024 Share Repurchase Plan and has no expiration date. In the second quarter of 2026, the Company repurchased 170,568 shares for approximately $24.2 million. — QUAKER CHEMICAL CORP 8-K filing · View on SEC EDGAR →

What this means

The new $250 million authorization replaces the prior 2024 plan and reflects management confidence in Quaker Houghton's operational momentum and cash position. With Q2'26 adjusted EBITDA up 13% year-over-year and net debt at 2.3x trailing twelve-month adjusted EBITDA, the company has sufficient financial capacity to fund both the buyback and an increased dividend. The $24.2 million in Q2 repurchases represents less than 1% of the new authorization and reduces share count modestly; at current execution levels, the full authorization would take several years to deploy. The program carries no expiration date, providing management ongoing discretion on timing and pace.

Frequently asked questions

Why did Quaker Houghton announce a new $250M repurchase program?: The company announced the program in conjunction with strong operational results—Q2'26 adjusted EBITDA was up 13% year-over-year and the company reported consecutive quarters of profitability growth. The new program replaces the prior 2024 Share Repurchase Plan and provides management with discretionary capital-return flexibility alongside the company's dividend increase.
What was the average price Quaker Houghton paid for shares in Q2'26?: The filing does not disclose the average price per share. It states only that 170,568 shares were repurchased for approximately $24.2 million in Q2'26. Investors can calculate the implied average price (~$142 per share) but the filing does not explicitly state this figure.
How long is the authorization valid?: The new program has no expiration date, unlike time-limited programs common in some companies. This gives management ongoing discretion to repurchase shares as market conditions and cash flow permit, without needing to renew authorization by a specific deadline.
How does the buyback fit with Quaker Houghton's debt levels?: The company's net debt stood at approximately $721 million at June 30, 2026, representing 2.3x trailing twelve-month adjusted EBITDA. At that leverage ratio, the company maintains financial flexibility to execute the buyback while servicing debt and funding operations, though debt reduction remains a priority given historical leverage targets in the 2.0x–2.5x range.
Does the filing specify how Quaker will execute the buyback?: No. The filing does not disclose whether repurchases will occur under Rule 10b-18 open-market purchases, a 10b5-1 trading plan, accelerated share repurchase agreements, or another mechanism. Additional details on execution strategy typically appear in separate Form 8-K or in the company's investor relations disclosures.
How much of the $250M authorization remains available?: The filing does not provide the dollar amount remaining under the authorization. With $24.2 million deployed in Q2'26, approximately $225.8 million would remain available as of the earnings release date (July 30, 2026), but formal disclosure of cumulative repurchases under the new plan may be found in subsequent quarterly SEC filings.

authorization industrials rule-10b-18-not-specified capital-allocation dividend-increase

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.